LEADER 01434nam  2200409   450 
001 9910707259503321
005 20160613083513.0
035   $a(CKB)5470000002462912
035   $a(OCoLC)951607368
035   $a(OCoLC)995470000002462912
035   $a(EXLCZ)995470000002462912
100   $a20160613d2014      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aLimitations in manufacturer reporting of average sales price data for Part B drugs
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2014.
215   $a1 online resource (23 pages) $cillustrations
300   $aTitle from title screen (viewed June 13, 2016).
300   $a"July 2014."
300   $a"OEI-12-13-00040."
320   $aIncludes bibliographical references.
517 1 $aLimitations in manufacturer reporting of average sales price data for Part B drugs
606   $aMedicaid$xFinance
606   $aDrugs$xPrices$zUnited States
606   $aPharmaceutical policy$zUnited States
615  0$aMedicaid$xFinance.
615  0$aDrugs$xPrices
615  0$aPharmaceutical policy
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707259503321
996   $aLimitations in manufacturer reporting of average sales price data for Part B drugs$93281979
997   $aUNINA